Novartis marks World CML Day with update on global research program to evaluate whether Ph+ CML patients can live treatment-free.
CML community recognizes September 22 as World CML Day to raise awareness
of the needs of patients living with CML
Novartis commemorates World CML Day, announcing 100+ study sites across 40
countries now enrolling patients to its global treatment-free remission clinical trials
Treatment-free remission program evaluates whether patients can maintain
undetectable levels of disease after stopping nilotinib therapy
